Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion

PHASE2TerminatedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

August 6, 2014

Primary Completion Date

April 27, 2016

Study Completion Date

May 17, 2016

Conditions
B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion
Interventions
DRUG

Idelalisib

150 mg tablets administered orally twice daily

DRUG

Rituximab

375 mg/m\^2 administered intravenously once weekly x 8 weeks

Trial Locations (56)

16

University Hospital Southampton NHS Trust, Southampton

1090

Medizinische Universität Wien, Univ. Klinik f. Innere Med. I, Abteilung für Hämatologie und Hämostaseologie, Vienna

2010

St Vincent's Hospital, Sydney, Darlinghurst

2217

St George Hospital, Kogarah

3000

University Hospital Leuven, Leuven

3065

St Vincent's Hospital, Melbourne, Fitzroy

4032

University of Debrecen HSC Institute of internal Medicine, Department of Hematology, Debrecen

4101

Icon Cancer Foundation, South Brisbane

5020

Univ. Klinik für Innere Medizin III LKH, Salzburg

8000

AZ Sint-Jan AV Brugge-Oostende, Bruges

9100

Aalborg University Hospital, Aalborg

10034

Faculty Hospital Kralovske Vinohrady, Prague

10043

SCDU Medicina II ed Ematologia, A.O.U. San Luigi Gonzaga, Orbassano

12808

Vseobecna Fakultim Nemocnice, Prague

19104

Hospital of the University of Pennsylvania, Abramson Cancer Center, Philadelphia

20125

Spitalul Clinic Colentina, Bucharest

20162

A.O.Niguarda Ca' Granda, Milan

25123

A.O.Spedali Civili Brescia, Brescia

27705

Duke University, Durham

28222

Hospital Universitario Puerta De Hierro, Madrid

29615

GHS Cancer Institute, Greenville

39008

Hospital Universitario Marques de Valdecilla, Santander

40138

"Institute of Hematology L. e A. Seràgnoli", Bologna

41124

Azienda Ospedaliero Universitaria Policlinico di Modena, Modena

46010

Hospital Clinico Universitario De Valencia (Chuv), Valencia

54511

Centre Hospitalier Universitaire Nancy, Nancy

59037

CHRU de Lille, Hopital Claude Huriez, Lille

60637

The University of Chicago Medicine, Chicago

60714

Illinois Cancer Specialists, Niles

63110

Washington University School of Medicine, St Louis

70852

Faculty hospital Ostrava, Ostrava-Poruba

75651

Hopital Pitie-Salpetriere, Paris

80303

Rocky Mountain Cancer Centers, Boulder

85710

Arizona Oncology Associates, PC - HOPE, Tucson

90603

Innovative Clinical Research Institute, Whittier

93009

Centre Hospitalier Universitaire Hôpital Avicenne, Bobigny

97213

Compass Oncology, Portland

97477

Willamette Valley Cancer Center and Research Institute, Springfield

500326

Emergency County Clinical Hospital Brasov, Brasov

700348

Institutul Regional de Oncologie Iasi, Iași

NSW 2170

Liverpool Hospital, Liverpool

A-6020

Innsbruck University Hospital, Inner Medicine,, Innsbruck

Unknown

University Hospital, Brno

Hemato-Onkologicka Klinika Fn, Olomuc

500 05

Faculty Hospital Hradec Kralove, Hradec Králové

80-952

Uniwersyteckie Centrum Kliniczne, Gdansk

36-200

Szpital Specjalistyczny w Brzozowie, Brzozów

30-510

Malopolskie Centrum Medyczne s.c., Krakow

93-510

Wojewodzki Szpital Specjalistyczny, Lodz

02-781

Centrum Onkologii-Instytut Marii Sklodowskiej -Curie klinika Nowotworow Ukladu Chlonnego, Warsaw

50-367

Samodzielny Publiczny Szpital Kliniczny, Wroclaw

1649-035

Centro Hospitalar De Lisboa Norte, E.P.E. - Hospital Santa Maria, Lisbon

4200-072

IPO Porto Francisco Gentil, E.P.E, Porto

08036

Hospital Clinic, Barcelona

LS9 7TF

Saint James's University Hospital, Leeds

L7 8XP

Royal Liverpool & Broadgreen Univ. Hospitals, Liverpool

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Gilead Sciences

INDUSTRY